Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
8 hedge funds and large institutions have $6.61M invested in Forward Pharma A/S American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
1% less capital invested
Capital invested by funds: $6.65M → $6.61M (-$42K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$98.2K |
| 2 |
Renaissance Technologies
New York
|
+$94.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$40.3K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10.9K |
FWP Hedge Fund Activity: Q1 2021 in Review
8 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2021, worth a combined $6.61M — down 0.63% from $6.65M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new FWP positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $98.2K. The largest seller was Morgan Stanley, cutting an estimated $40.3K.
- 8 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2021, up from 7 in Q4 2020.
- Funds reported $6.61M of Forward Pharma A/S American Depositary Shares stock for Q1 2021, down 0.63% quarter-over-quarter.
- 1 fund opened new Forward Pharma A/S American Depositary Shares positions in Q1 2021 and 0 closed out, a net change of +1 holder.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q1 2021 was Citadel Advisors, an estimated $98.2K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q1 2021 was Morgan Stanley, an estimated $40.3K sold.
Based on aggregated 13F filings for Q1 2021.